Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.45 – $0.70
19% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.92B | $2.23B | $2.66B | $5.22B | $3.61B | $4.12B | $5.72B | $7.86B |
| Cost of revenue | $973.1M | $1.14B | $1.31B | $2.42B | $2.14B | $2.60B | $3.54B | $4.50B |
| Gross profit | $948.4M | $1.08B | $1.34B | $2.80B | $1.46B | $1.52B | $2.18B | $3.35B |
| Gross margin | 49.4% | 48.7% | 50.5% | 53.7% | 40.6% | 37.0% | 38.1% | 42.7% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $684.9M | $790.8M | $985.5M | $2.26B | $832.2M | $737.8M | $1.21B | $2.12B |
| EBITDA | $806.6M | $972.6M | $1.22B | $2.57B | $1.06B | $1.28B | $2.09B | $2.89B |
| Net income | $502.1M | $510.9M | $594.0M | $1.41B | $541.1M | $510.3M | $1.08B | $1.26B |
| Net margin | 26.1% | 22.9% | 22.4% | 27.0% | 15.0% | 12.4% | 18.8% | 16.1% |
| EPS (diluted) | 0.84 | 0.81 | 0.99 | 2.35 | 0.90 | 0.85 | 1.82 | 2.17 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $9.6B | $2.86 | $2.86–$2.86 | 1 |
| 2027 | $11.4B | $3.59 | $3.59–$3.59 | 1 |
| 2028 | $12.7B | $4.19 | $4.19–$4.19 | 1 |
| 2029 | $13.7B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
INTEGRATED DIGNSICS NEW
No one on the platform currently holds IDGXF.
No tracked institution reports a position in IDGXF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-29 | $0.0085 | 2026-06-22 |
| 2025-09-12 | $0.0170 | 2025-10-03 |
| Execution date | Ratio |
|---|---|
| 2020-12-31 | 4-for-1 |
No one on the platform has traded IDGXF yet.
| -57.20% |
| $2M |
| — |
| GENEGenetic Technologies Limited | $0.77 | +0.00% | $111M | — |
| GTHGenetron Holdings Limited | $4.03 | +0.12% | $127M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.3× earnings vs its 0.4× historical median P/E.
Fair value ≈ $0.59 · price $0.49 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.